Your browser doesn't support javascript.
loading
Use of Everolimus After Multivisceral Transplantation: A Report of Two Cases.
Rao, B; Segovia, M C; Kazimi, M; Parekh, R; Raoufi, M; Jafri, S-M.
Affiliation
  • Rao B; Department of Internal Medicine, Henry Ford Hospital, Detroit, Michigan.
  • Segovia MC; Division of Gastroenterology and Hepatology, Henry Ford Hospital, Detroit, Michigan. Electronic address: msegovi3@hfhs.org.
  • Kazimi M; Division of Transplant and Hepatobiliary Surgery, Henry Ford Hospital, Detroit, Michigan.
  • Parekh R; Division of Gastroenterology and Hepatology, Henry Ford Hospital, Detroit, Michigan.
  • Raoufi M; Department of Pathology, Henry Ford Hospital, Detroit, Michigan.
  • Jafri SM; Division of Gastroenterology and Hepatology, Henry Ford Hospital, Detroit, Michigan.
Transplant Proc ; 48(2): 485-8, 2016 Mar.
Article in En | MEDLINE | ID: mdl-27109983

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Neuroendocrine Tumors / Everolimus / Gastrointestinal Neoplasms / Immunosuppressive Agents / Intestines / Neoplasm Recurrence, Local Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Transplant Proc Year: 2016 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Neuroendocrine Tumors / Everolimus / Gastrointestinal Neoplasms / Immunosuppressive Agents / Intestines / Neoplasm Recurrence, Local Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Transplant Proc Year: 2016 Document type: Article